Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,925 | 308 | 90.9% |
| Education | $693.40 | 16 | 9.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $975.56 | 27 | $0 (2024) |
| Amgen Inc. | $848.47 | 36 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $813.55 | 34 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $607.23 | 38 | $0 (2023) |
| Genentech USA, Inc. | $462.14 | 22 | $0 (2020) |
| Janssen Biotech, Inc. | $315.32 | 3 | $0 (2024) |
| PFIZER INC. | $302.09 | 30 | $0 (2020) |
| EMD Serono, Inc. | $285.62 | 4 | $0 (2024) |
| Incyte Corporation | $278.42 | 7 | $0 (2020) |
| Merck Sharp & Dohme LLC | $270.04 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $617.55 | 10 | EMD Serono, Inc. ($160.62) |
| 2023 | $520.19 | 8 | E.R. Squibb & Sons, L.L.C. ($154.09) |
| 2022 | $976.10 | 12 | E.R. Squibb & Sons, L.L.C. ($330.79) |
| 2021 | $274.84 | 4 | AstraZeneca Pharmaceuticals LP ($244.05) |
| 2020 | $1,188 | 42 | AstraZeneca Pharmaceuticals LP ($497.52) |
| 2019 | $1,250 | 78 | Amgen Inc. ($164.97) |
| 2018 | $1,268 | 72 | Amgen Inc. ($225.58) |
| 2017 | $1,524 | 98 | Incyte Corporation ($264.80) |
All Payment Transactions
324 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $77.25 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $61.56 | General |
| 08/22/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $61.56 | General |
| 08/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $37.50 | General |
| 05/11/2024 | Amgen Inc. | IMDELLTRA (AMG 757) (Biological) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: Hematology | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $64.52 | General |
| Category: Oncology | ||||||
| 02/22/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Oncology | ||||||
| 08/29/2023 | Janssen Scientific Affairs, LLC | RYBREVANT (Drug), TECVAYLI | Food and Beverage | In-kind items and services | $51.67 | General |
| Category: Oncology | ||||||
| 07/15/2023 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Oncology | ||||||
| 07/13/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Oncology | ||||||
| 05/18/2023 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $67.85 | General |
| 04/27/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $57.86 | General |
| 02/23/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $38.92 | General |
| Category: Oncology | ||||||
| 02/06/2023 | E.R. Squibb & Sons, L.L.C. | SPRYCEL (Drug) | Education | In-kind items and services | $29.09 | General |
| Category: Oncology | ||||||
| 11/10/2022 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $125.81 | General |
| Category: Oncology | ||||||
| 09/28/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $71.70 | General |
| Category: Oncology | ||||||
| 08/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Diabetes | ||||||
| 07/15/2022 | Janssen Scientific Affairs, LLC | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $70.91 | General |
| Category: Oncology | ||||||
| 07/06/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $64.51 | General |
| Category: Oncology | ||||||
| 05/26/2022 | GENZYME CORPORATION | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $66.72 | General |
| Category: Oncology | ||||||
| 04/23/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Oncology | ||||||
About Dr. James Hueftle, MD
Dr. James Hueftle, MD is a Geriatric Medicine healthcare provider based in Anaconda, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528041571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Hueftle, MD has received a total of $7,619 in payments from pharmaceutical and medical device companies, with $617.55 received in 2024. These payments were reported across 324 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($6,925).
Practice Information
- Specialty Geriatric Medicine
- Other Specialties Hematology & Oncology
- Location Anaconda, MT
- Active Since 11/23/2005
- Last Updated 02/11/2019
- Taxonomy Code 207QG0300X
- Entity Type Individual
- NPI Number 1528041571
Products in Payments
- OPDIVO (Biological) $695.78
- TAGRISSO (Drug) $463.69
- TECENTRIQ (Biological) $279.84
- KEYTRUDA (Biological) $260.38
- LIBTAYO (Biological) $228.34
- Cabometyx (Drug) $220.04
- ZEJULA (Drug) $186.93
- AFINITOR (Drug) $182.60
- JAKAFI (Drug) $182.47
- RYBREVANT (Drug) $176.67
- Lenvima (Drug) $164.91
- XTANDI (Drug) $157.67
- CALQUENCE (Drug) $137.54
- Neulasta (Biological) $136.54
- DARZALEX (Biological) $135.42
- IMFINZI (Drug) $135.33
- Nplate (Biological) $127.78
- IMBRUVICA (Drug) $125.81
- BAVENCIO (Drug) $125.00
- IMFINZI (Biological) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.